These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22788747)

  • 21. Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells.
    Brenner C; Kränkel N; Kühlenthal S; Israel L; Remm F; Fischer C; Herbach N; Speer T; Grabmaier U; Laskowski A; Gross L; Theiss H; Wanke R; Landmesser U; Franz WM
    Int J Cardiol; 2014 Nov; 177(1):266-75. PubMed ID: 25499391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
    Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
    Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
    Ishii M; Shibata R; Kondo K; Kambara T; Shimizu Y; Tanigawa T; Bando YK; Nishimura M; Ouchi N; Murohara T
    J Biol Chem; 2014 Sep; 289(39):27235-27245. PubMed ID: 25100725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells.
    Zhou J; Cheng M; Liao YH; Hu Y; Wu M; Wang Q; Qin B; Wang H; Zhu Y; Gao XM; Goukassian D; Zhao TC; Tang YL; Kishore R; Qin G
    PLoS One; 2013; 8(5):e63126. PubMed ID: 23704894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1-dependent and independent effects and molecular mechanisms of a dipeptidyl peptidase 4 inhibitor in vascular endothelial cells.
    Hu Y; Liu H; Simpson RW; Dear AE
    Mol Biol Rep; 2013 Mar; 40(3):2273-9. PubMed ID: 23187735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.
    Nakamura K; Oe H; Kihara H; Shimada K; Fukuda S; Watanabe K; Takagi T; Yunoki K; Miyoshi T; Hirata K; Yoshikawa J; Ito H
    Cardiovasc Diabetol; 2014 Jul; 13():110. PubMed ID: 25074318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
    Li H; Wang YS
    Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
    Al-Awar A; Almási N; Szabó R; Takacs I; Murlasits Z; Szűcs G; Török S; Pósa A; Varga C; Kupai K
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
    Lu HY; Huang CY; Shih CM; Chang WH; Tsai CS; Lin FY; Shih CC
    PLoS One; 2015; 10(4):e0121077. PubMed ID: 25876091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
    Kishimoto M; Noda M
    Cardiovasc Diabetol; 2011 Dec; 10():115. PubMed ID: 22189184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia.
    Yip HK; Sun CK; Tsai TH; Sheu JJ; Kao YH; Lin YC; Shiue YL; Chen YL; Chai HT; Chua S; Ko SF; Leu S
    Int J Cardiol; 2013 Sep; 168(1):226-36. PubMed ID: 23063135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system.
    Wang CH; Cherng WJ; Yang NI; Hsu CM; Yeh CH; Lan YJ; Wang JS; Verma S
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R811-8. PubMed ID: 18094068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.
    Herman GA; Bergman A; Stevens C; Kotey P; Yi B; Zhao P; Dietrich B; Golor G; Schrodter A; Keymeulen B; Lasseter KC; Kipnes MS; Snyder K; Hilliard D; Tanen M; Cilissen C; De Smet M; de Lepeleire I; Van Dyck K; Wang AQ; Zeng W; Davies MJ; Tanaka W; Holst JJ; Deacon CF; Gottesdiener KM; Wagner JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4612-9. PubMed ID: 16912128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice.
    Tongers J; Knapp JM; Korf M; Kempf T; Limbourg A; Limbourg FP; Li Z; Fraccarollo D; Bauersachs J; Han X; Drexler H; Fiedler B; Wollert KC
    Cardiovasc Res; 2008 May; 78(2):294-300. PubMed ID: 18093990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
    Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
    Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2009 Mar; 58(3):641-51. PubMed ID: 19073764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes.
    Gallwitz B
    Drugs Today (Barc); 2007 Jan; 43(1):13-25. PubMed ID: 17315049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.
    Read PA; Khan FZ; Heck PM; Hoole SP; Dutka DP
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):195-201. PubMed ID: 20075143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.